Quotient Clinical showcases RapidFACT™ and six poster publications at AAPS

Oct. 1, 2014 - PRLog -- Quotient Clinical, the Translational Pharmaceutics™ company, will present the third annual RapidFACT™ (Rapid Formulation development And Clinical Testing) User Group Meeting, as well as six poster publications, at the forthcoming 2014 AAPS Annual Meeting and Exposition from the 2^nd to 6^th of November in San Diego, USA.

The RapidFACT User Group Meeting will focus on the latest applications of formulation design space to overcome solubility and modified release drug delivery challenges, and will include case study presentations from two industry speakers. For full program details, and to register, click here (https://register.quotientclinical.net/?event=RAPIDFACT).

The poster publications describe completed programs using Quotient Clinical’s Translational Pharmaceutics platform for a variety of applications. Details of the poster presentations are:

Rapid formulation development and clinical evaluation of ocular formulations of AMA0076 based upon intra-ocular pressure lowering

Abstract ID: AM-14-2692, Poster ID: M1076

Monday, November 3^rd, 1:30 - 5:00 pm, Halls B - F

Adaptive manufacturing: a new paradigm to improve efficiency and effectiveness in early oncology development

Abstract ID: AM-14-1787, Poster ID: W4282

Wednesday, November 5^th, 9:30 am - 12:30 pm, Halls B - F

Application of formulation design space to drive rapid development and clinical optimization of drug products – 5 years of innovation

Abstract ID: AM-14-3060, Poster ID: W4020

Wednesday, November 5^th, 9:30 am - 12:30 pm, Halls B - F

Assessment of the safety, tolerability and pharmacokinetics of single doses of oral dexanabinol in healthy subjects using an adaptive protocol

Abstract ID: AM-14-2471, Poster ID: W5279

Wednesday, November 5^th, 1:30 - 4:30 pm, Hall A

Two approaches for determining absolute bioavailability and intravenous pharmacokinetics in first-in-human studies for oral drug products

Abstract ID: AM-14-2494, Poster ID: W5280

Wednesday, November 5^th, 1:30 - 4:30 pm, Hall A

Rapid formulation development and clinical evaluation of enabled formulations of IDX-719

Abstract ID: AM-14-2678, Poster ID: R6179

Thursday, November 6^th, 8:30 - 11:30 am, Hall A

Quotient Clinical will be located at exhibition booth #1448.  Should you wish to arrange a meeting, please email john.mcdermott@quotientclinical.com.